Home 2023

Hematopoietic stem cell

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar
GEN Edge

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar

Alex Philippidis -
0
Genotoxic Effects by Base and Prime Editors in Human HSPCs Aren’t Surprising, Says Pioneer
Genome Editing

Genotoxic Effects by Base and Prime Editors in Human HSPCs Aren’t Surprising, Says Pioneer

Jonathan D Grinstein, PhD -
0
Base Editing Tweaks HSC Epitopes for Targeted Immunotherapy
Cancer

Base Editing Tweaks HSC Epitopes for Targeted Immunotherapy

Jonathan D Grinstein, PhD -
0
Humanized Animal Models Boost Translational Value
Insights

Humanized Animal Models Boost Translational Value

Kathy Vuksanaj -
0
In Vivo Genome Editing of Stem Cells Induced by LNP-Based Delivery of mRNA
Cancer

In Vivo Genome Editing of Stem Cells Induced by LNP-Based Delivery of mRNA

Jonathan D Grinstein, PhD -
0
Base Editing Beats Other Genome Editing Strategies for Treating Sickle Cell Disease
Genome Editing

Base Editing Beats Other Genome Editing Strategies for Treating Sickle Cell Disease

Julianna LeMieux, PhD -
0
Case Study: Genetic Engineering of Adoptive Cell Therapies
Drug Discovery

Case Study: Genetic Engineering of Adoptive Cell Therapies

Kathy Vuksanaj -
0
Prime-Edited Patient Blood Stem Cells Fully Engraft and Rescue Sickle Cell Mice
Genome Editing

Prime-Edited Patient Blood Stem Cells Fully Engraft and Rescue Sickle Cell Mice

Jonathan D Grinstein, PhD -
0
Genenta Science and AGC Biologics Sign Development and Manufacturing Deal
Bioprocessing

Genenta Science and AGC Biologics Sign Development and Manufacturing Deal

John Sterling -
0
Hit Pause: The Read-Across to Graphite Bio’s CEDAR Sickle Cell Trial Suspension
GEN Edge

Hit Pause: The Read-Across to Graphite Bio’s CEDAR Sickle Cell Trial Suspension

Jonathan D Grinstein, PhD -
0
123...10Page 1 of 10
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.